Open Insider Trading Activity for Nektar Therapeutics Chief R&D Officer Zalevsky Jonathan
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting NKTR | 2026-05-21 | 2026-05-19 | Nektar Therapeutics | Zalevsky Jonathan | Chief R&D Officer | Sell | 1 | 199 | $65.51 | $13,036.49 | 0.94% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting NKTR | 2026-02-20 | 2026-02-18 | Nektar Therapeutics | Zalevsky Jonathan | Chief R&D Officer | Sell | 1 | 180 | $73.00 | $13,140.00 | 0.84% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting NKTR | 2025-05-21 | 2025-05-19 | Nektar Therapeutics | Zalevsky Jonathan | Chief R&D Officer | Sell | 1 | 10,712 | $0.67 | $7,177.04 | 3.38% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting NKTR | 2025-02-21 | 2025-02-19 | Nektar Therapeutics | Zalevsky Jonathan | Chief R&D Officer | Sell | 1 | 10,300 | $1.01 | $10,403.00 | 3.15% | View Filing |